A recent study published in Clinical Pharmacology & Therapeutics challenges conventional wisdom about the interaction between cannabidiol (CBD) and tetrahydrocannabinol (THC), revealing that it may be not only incorrect but actually the opposite of what is commonly believed.
Contrary to popular belief that CBD can reduce the negative effects of THC, the study found that CBD did not mitigate these adverse effects. In fact, a high dose of CBD (450 mg) significantly enhanced the effects of THC, likely due to a pharmacokinetic interaction that increased THC levels in the bloodstream.
Cannabis has gained attention not only as a recreational drug but also for its potential therapeutic benefits, especially in pain management. THC, the main psychoactive compound in cannabis, is known for its analgesic properties but also for causing a range of adverse effects, such as cognitive impairment, anxiety, and psychomotor disturbances. CBD, on the other hand, is non-intoxicating and has been suggested to counteract some of THC’s negative effects. This belief has led to the widespread use of CBD-rich cannabis products, both for recreational and medicinal purposes.
However, the scientific evidence supporting the idea that CBD can mitigate THC’s adverse effects is inconsistent. Some studies have shown that CBD can reduce THC-induced anxiety and psychosis, while others have found no such protective effects.
Read the full article at PsyPost.
